Jump to content

MRNA vaccine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wootini (talk | contribs) at 03:29, 21 March 2020 (Clarified further). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

An RNA vaccine is a type of vaccine which is composed of the nucleic acid RNA, packaged within a vector such as lipid nanoparticles[1]. Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will bind to potential pathogens. This is accomplished when the RNA from the vaccine (a messenger RNA) is delivered into cells in the body, which then produce proteins that mimic proteins from the pathogen. These proteins are then used by the immune system to produce antibodies against the pathogen, causing future protection from the pathogen.[2]

See also

References

  1. ^ "mRNA Platform". CureVac. Retrieved 2020-03-21.{{cite web}}: CS1 maint: url-status (link)
  2. ^ Hubaud, Alexis. "RNA vaccines: a novel technology to prevent and treat disease". sitn.hms.harvard.edu. Harvard University. Retrieved 17 February 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=MRNA_vaccine&oldid=946587643"